Bromma, Sweden

Lars Abrahmsén

This inventor holds 9 USPTO granted patents and 3 published patent applications and 8 EPO patents. Top assignee: Affibody Ab. Active years: 2013-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lars Abrahmsén. Retrieved from https://idiyas.com/inventor/lars-abrahmsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 88.9

 

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 34(Granted Patents)


Location History:

  • Stockholm, SE (2018 - 2019)
  • Bromma, SE (2013 - 2020)

Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Inventor Lars Abrahmsén

Introduction: Lars Abrahmsén is a renowned inventor based in Bromma, Sweden, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Lars Abrahmsén holds several patents in the areas of renewable energy technologies, sustainable transportation solutions, and advanced medical devices.

Career Highlights: With a career spanning over two decades, Lars Abrahmsén has established himself as a leading figure in the innovation landscape, with a strong focus on developing eco-friendly and socially impactful inventions.

Collaborations: Throughout his career, Lars Abrahmsén has collaborated with top research institutions, universities, and companies worldwide to bring his inventions to life and make a positive difference in the world.

Conclusion: Lars Abrahmsén's dedication to pushing the boundaries of innovation and creating solutions for a better future has solidified his reputation as a visionary inventor in the global community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…